Warrant holders should expect zero recovery; the delisting confirms the warrants have no remaining economic value. Monitor for any subsequent corporate action (e.g., reverse split, restructuring) that could affect common stock.
Price Chart
Executive Summary
Nasdaq filed a Form 25-NSE to delist Jasper Therapeutics' redeemable warrants (each ten warrants exercisable for one share of common stock at $115.00) under Rule 12d2-2(a)(2), effective September 24, 2026. The delisting is due to the warrants' maturity, redemption, or retirement, removing the security from Nasdaq listing and SEC registration.
Key Facts
- Form 25-NSE filed by Nasdaq Stock Market LLC to delist Jasper Therapeutics' redeemable warrants.
- Each warrant is exercisable for one share of voting common stock at $115.00 per share.
- Delisting effective September 24, 2026, under SEC Rule 12d2-2(a)(2) for matured/retired securities.
- The warrants are being removed from listing and registration on Nasdaq.
Financial Impact
Warrant delisting eliminates any remaining equity-linked upside for warrant holders; the $115.00 exercise price is far above any plausible common stock value for a pre-revenue biotech, making the warrants worthless.
Risk Factors
- Warrant delisting removes a potential source of future equity capital if exercised.
- May signal broader financial distress or lack of investor interest in the company's equity-linked securities.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (Primary) | 0001354457-26-000914 |
| Document: 0001354457-26-000914-index-headers.html | 0001354457-26-000914 |
| Document: 0001354457-26-000914-index.html | 0001354457-26-000914 |
| Document: 0001354457-26-000914.txt | 0001354457-26-000914 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | SC TO-I/A | $0.5100 | awaiting T+5 | — | $0.5054 (−0.90%) |
Oct 20, 2026 6d ago | DEF 14A | $0.4999 | awaiting T+5 | — | $0.5054 (+1.10%) |
Oct 15, 2026 11d ago | 8-K | $0.5321 $0.4956 | ▼ −6.86% | ▼ −5.85% | $0.5054 (−5.02%) |
Oct 15, 2026 11d ago | Press Release | $0.5320 $0.4960 | ▲ +6.77% | ▲ +5.75% | $0.5054 (+5.00%) |
Oct 14, 2026 12d ago | S-3 | $0.5321 $0.4956 | ▲ +6.86% | ▲ +5.85% | $0.5054 (+5.02%) |
Oct 7, 2026 19d ago | 8-K | $0.5697 $0.5010 | ▼ −12.06% | ▼ −11.08% | $0.5054 (−11.29%) |
Oct 7, 2026 19d ago | SC TO-I | $0.5697 $0.5010 | ▼ −12.06% | ▼ −11.08% | $0.5054 (−11.29%) |
Sep 24, 2026 4w ago | 25-NSE | $0.6091 $0.5652 | ▲ +7.21% | ▲ +6.99% | $0.5054 (+17.03%) |
Aug 14, 2026 10w ago | Press Release | $0.7901 $0.7160 | ▼ −9.38% | ▼ −8.01% | $0.5054 (−36.03%) |
Jul 31, 2026 12w ago | 8-K | $0.6300 $0.7095 | ▲ +12.62% | ▲ +9.11% | $0.5054 (−19.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers